HOXA10 deteriorates gastric cancer through activating JAK1/STAT3 signaling pathway

Background: HOXA10 has been reported to be deregulated in many kinds of cancers including gastric cancer. But its role in gastric cancer progression is controversial. Therefore, the current study was performed to explore the role and mechanism of HOXA10 in gastric cancer. Materials and methods: IHC...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wenchao, Wu, Gang, Zhu, Yuanzeng, Zhang, Wei, Zhang, Han, Zhou, Yang, Sun, Peichun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642621/
https://www.ncbi.nlm.nih.gov/pubmed/31406476
http://dx.doi.org/10.2147/CMAR.S201342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642621/
https://www.ncbi.nlm.nih.gov/pubmed/31406476
http://dx.doi.org/10.2147/CMAR.S201342

Ejemplares similares